Morrow, Jarrett D.
Zhou, Xiaobo
Lao, Taotao
Jiang, Zhiqiang
DeMeo, Dawn L.
Cho, Michael H.
Qiu, Weiliang
Cloonan, Suzanne
Pinto-Plata, Victor
Celli, Bartholome
Marchetti, Nathaniel
Criner, Gerard J.
Bueno, Raphael
Washko, George R.
Glass, Kimberly
Quackenbush, John
Choi, Augustine M. K.
Silverman, Edwin K.
Hersh, Craig P.
Article History
Received: 8 September 2016
Accepted: 6 February 2017
First Online: 13 March 2017
Competing interests
: Drs. Morrow, Zhou, Lao, Jiang, DeMeo, Cho, Qiu, Cloonan, Pinto-Plata, Celli, Marchetti, Criner, Bueno, Glass, Quackenbush, Choi report no competing interests related to this manuscript. Dr. Washko has been a consultant for GSK, Genentech, Emmes, PulmonX. Dr. Silverman has received honoraria and consulting fees from Merck, grant support and consulting fees from GlaxoSmithKline, and honoraria from Novartis. Dr. Hersh has been a consultant for Mylan, Concert Pharmaceuticals and AstraZeneca.